These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 35046902)

  • 1. Molecular and Cellular Bases of Lipodystrophy Syndromes.
    Zammouri J; Vatier C; Capel E; Auclair M; Storey-London C; Bismuth E; Mosbah H; Donadille B; Janmaat S; Fève B; Jéru I; Vigouroux C
    Front Endocrinol (Lausanne); 2021; 12():803189. PubMed ID: 35046902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to diagnose a lipodystrophy syndrome.
    Vantyghem MC; Balavoine AS; Douillard C; Defrance F; Dieudonne L; Mouton F; Lemaire C; Bertrand-Escouflaire N; Bourdelle-Hego MF; Devemy F; Evrard A; Gheerbrand D; Girardot C; Gumuche S; Hober C; Topolinski H; Lamblin B; Mycinski B; Ryndak A; Karrouz W; Duvivier E; Merlen E; Cortet C; Weill J; Lacroix D; Wémeau JL
    Ann Endocrinol (Paris); 2012 Jun; 73(3):170-89. PubMed ID: 22748602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin replacement therapy in the management of lipodystrophy syndromes.
    Vigouroux C; Mosbah H; Vatier C
    Ann Endocrinol (Paris); 2024 Jun; 85(3):201-204. PubMed ID: 38871500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial lipodystrophy: Clinical presentation and treatment.
    Mosbah H; Vatier C; Vigouroux C
    Ann Endocrinol (Paris); 2024 Jun; 85(3):197-200. PubMed ID: 38871513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy.
    Akinci G; Akinci B
    Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(2):74-8. PubMed ID: 26556498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipodystrophies: adipose tissue disorders with severe metabolic implications.
    Cortés VA; Fernández-Galilea M
    J Physiol Biochem; 2015 Sep; 71(3):471-8. PubMed ID: 25833179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Options for Lipodystrophy in Children.
    Mainieri F; Tagi VM; Chiarelli F
    Front Endocrinol (Lausanne); 2022; 13():879979. PubMed ID: 35600578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function.
    Bruder-Nascimento T; Kress TC; Belin de Chantemele EJ
    F1000Res; 2019; 8():. PubMed ID: 31656583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipodystrophy as a target to delay premature aging.
    Costa DG; Ferreira-Marques M; Cavadas C
    Trends Endocrinol Metab; 2024 Feb; 35(2):97-106. PubMed ID: 37968143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
    Meehan CA; Cochran E; Kassai A; Brown RJ; Gorden P
    Expert Rev Clin Pharmacol; 2016; 9(1):59-68. PubMed ID: 26465174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Metreleptin in Pediatric Patients With Lipodystrophy.
    Brown RJ; Meehan CA; Cochran E; Rother KI; Kleiner DE; Walter M; Gorden P
    J Clin Endocrinol Metab; 2017 May; 102(5):1511-1519. PubMed ID: 28324110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seipin Deficiency as a Model of Severe Adipocyte Dysfunction: Lessons from Rodent Models and Teaching for Human Disease.
    Magré J; Prieur X
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications of lipodystrophy syndromes.
    Akinci G; Celik M; Akinci B
    Presse Med; 2021 Nov; 50(3):104085. PubMed ID: 34728268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipodystrophic syndromes: From diagnosis to treatment.
    Sollier C; Vatier C; Capel E; Lascols O; Auclair M; Janmaat S; Fève B; Jéru I; Vigouroux C
    Ann Endocrinol (Paris); 2020 Feb; 81(1):51-60. PubMed ID: 31982105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary disease of adipose tissue: When to think about and how to evaluate it in clinical practice?
    Vatier C; Vigouroux C; Mosbah H
    Ann Endocrinol (Paris); 2024 Jun; 85(3):190-194. PubMed ID: 38871502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy.
    Nagayama A; Ashida K; Watanabe M; Moritaka K; Sonezaki A; Kitajima Y; Takahashi H; Yoshinobu S; Iwata S; Yasuda J; Hasuzawa N; Ozono S; Motomura S; Nomura M
    Front Endocrinol (Lausanne); 2021; 12():690996. PubMed ID: 34135866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of lipodystrophy: a step-by-step approach.
    Araújo-Vilar D; Santini F
    J Endocrinol Invest; 2019 Jan; 42(1):61-73. PubMed ID: 29704234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recognize rare diseases by the adipose tissue : Lipodystrophy-actually simple but nevertheless often overlooked].
    Wabitsch M; V Schnurbein J
    Internist (Berl); 2020 Oct; 61(10):1063-1075. PubMed ID: 32930809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for leptin-replacement therapy for severe lipodystrophy.
    Oral EA; Chan JL
    Endocr Pract; 2010; 16(2):324-33. PubMed ID: 20061299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin Attenuates Cardiac Hypertrophy in Patients With Generalized Lipodystrophy.
    Nguyen ML; Sachdev V; Burklow TR; Li W; Startzell M; Auh S; Brown RJ
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4327-e4339. PubMed ID: 34223895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.